On 17 June, an online EPAD–AMYPAD imaging workshop was organised, aiming to engage researchers across the scientific community in the ongoing analyses currently performed in these two large European consortia, funded by the Innovative Medicines Initiative (IMI). Through these two projects, an abundance of longitudinal MR and amyloid PET imaging data in a pre-dementia Alzheimer’s…
DetailsA new article from the EPAD consortium entitled “”Ready for What?”: Timing and Speculation in Alzheimer’s Disease Drug Development” has recently been published in SAGE Journals. In this paper, authors examined challenges of time and recruitment in the context of the move to precision or stratified medicine, focusing on “readiness”: the state of being ready…
DetailsAs previously announced, the latest and final EPAD dataset called Version.IMI (V.IMI) is now available in the Alzheimer’s Disease Workbench to provide even greater value to the global neuroscience research community. All the data collected and processed annually during the IMI period of EPAD from research participants throughout their participation in the Longitudinal Cohort Study…
DetailsA new article from the EPAD consortium entitled “Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort” has recently been published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. In this article, the ATN classification was operationalized in the first 1500 participants consented in the EPAD…
DetailsThe European Prevention of Alzheimer’s Dementia (EPAD) consortium, in their partnership with Aridhia, are proud to announce that the EPAD V.IMI dataset has been incorporated into the Alzheimer’s Disease Workbench to provide even greater value to the global neuroscience research community. The latest and final EPAD dataset went into open access to all researchers from…
DetailsA key achievement of the EPAD project was the establishment of a Longitudinal Cohort Study (LCS) that has screened over 2,000 participants and collected a wide range of cognitive, clinical, neuroimaging and biomarker data to help further our understanding of the early stages of Alzheimer’s disease. EPAD has made this database open access and publicly…
DetailsAlzheimer Europe has published a new edition of its “Dementia in Europe” policy magazine, in an electronic format. The first section of the magazine includes a closing article on the EPAD project in which Alzheimer Europe has been involved. Our co-leads Craig Ritchie and Serge Van der Geyten have been interviewed and reflect on the…
DetailsAt an online European Parliament workshop hosted by Deirdre Clune MEP (Ireland), Alzheimer Europe launched a new report “Data Sharing in Dementia Research”, which reviews recent changes in EU research policy and sets out recommendations to improve data sharing in dementia research. In this report, Alzheimer Europe evaluates the legal and policy landscapes that dementia…
DetailsOn 17 February, we were pleased to hold the first local EPAD community meeting among the Scottish research sites, collaborators, academics and scientists who have been involved in the EPAD Longitudinal Cohort Study (LCS) throughout the IMI funded period and now continue to contribute to the study locally. The first local EPAD community meeting focused…
DetailsOn 1 February, the members of the Neuronet (Efficiently Networking European Neurodegeneration Research) programme announced the launch of a pan-European Knowledge Base which brings together key information about the 18 projects of the Innovative Medicines Initiative (IMI) neurodegeneration (ND) portfolio, including the EPAD project. This comprehensive resource is an integral part of Neuronet’s endeavour to…
Details
